Innovega’s eMacula System Addresses Growing Number of Myopia Cases Worldwide

In response to the rising global incidence of myopia, Innovega Inc., a developer of stylish, lightweight wearable displays that feature a high-resolution, panoramic-field-of-view system for medical, consumer, and industrial application, today released a roadmap outlining the company’s approach and mission to provide a new solution for the visually impaired by addressing myopia, or nearsightedness, and how it affects billions worldwide.

“We believe our eMacula™ system, now on the regulatory path to FDA market clearance, will offer patients with vision loss from myopia-related retinal degeneration an integrated vision correction system that combines lightweight eyewear with our high-resolution, unobstructed-field-of-view iOptik® smart contact lens. The initial target market, with FDA market clearance, would be visually impaired patients who require levels of magnification that are not possible with existing contact lenses or eyeglasses,” said Mr. Steve Willey, Co-Founder and Chief Executive Officer of Innovega.